Video

Dr. Mesa on the Unique Characteristics of Pacritinib in Myelofibrosis

Author(s):

Ruben A. Mesa, MD, discusses the unique characteristics of pacritinib in the treatment of patients with myelofibrosis.

Ruben A. Mesa, MD, director of the Mays Cancer Center at UT Health San Antonio, MD Anderson Cancer Center, discusses the unique characteristics of pacritinib (SB1518) in the treatment of patients with myelofibrosis.

One of the unique aspects of JAK2 inhibitor pacritinib is the safety and efficacy it has demonstrated in patients with low platelet counts, Mesa says. Additionally, the drug is effective against splenomegaly, as well as disease symptoms for patients with myelofibrosis, Mesa adds.

Many JAK2 inhibitors have thrombocytopenia as a dose limiting toxicity, and none of the current FDA approved JAK inhibitors, such as ruxolitinib (Jakafi) and fedratinib (Inrebic), have an indication for individuals with a platelet count of less than 50,000. Having application in this patient population sets pacritinib apart from other available treatments, Mesa concludes.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Expert Perspectives on Applying Recent Evidence to Practice in the Management of Newly Diagnosed Multiple Myeloma
Video

Expert Perspectives on Applying Recent Evidence to Practice in the Management of Newly Diagnosed Multiple Myeloma

Jun 19th 2025 - Jul 25th 2025

online-activity
Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies
Audio

Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies

Jun 18th 2025 - Jun 19th 2026

online-activity
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity